logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Liability in prescribing choice : the example of the antidepressants.

    Article - En anglais

    Objective 

    The aim of this study is to review issues of legal liability in prescribing choice.

    Prescribing not only occurs in a medical setting, but also in a social and legal context in this era of evidence-based medicine and greater consumer awareness.

    Prescribers may be unaware of the legal consequences of medical decision-making and prescribing choice.

    This issue affects all areas of medicine and can be illustrated by antidepressant choice for major depression.

    Method 

    A review was undertaken of liability issues that may arise in the context of prescribing, with particular reference to prescribing antidepressants.

    Results 

    There are legal precedents which illustrate prescribers'potential liability.

    These impose duties on the prescriber including those of care, to inform, and to respond to patients'wishes.

    In particular, the duty of care requires that if medicines are of equal efficacy, one should prescribe the best tolerated and least toxic medicine that is most likely to be taken at an effective dose for an adequate duration.

    While older and newer antidepressants are generally of equal efficacy, the newer agents have higher tolerability, lower toxicity and are less likely to be associated with treatment failure (due to sub-therapeutic dose regimens, or the patient discontinuing medication), disabling psychomotor impairment, dietary interaction or fatal overdose. (...)

    Mots-clés Pascal : Prescription médicale, Antidépresseur, Psychotrope, Législation, Responsabilité professionnelle, Toxicité, Santé mentale, Australie, Océanie, Homme

    Mots-clés Pascal anglais : Medical prescription, Antidepressant agent, Psychotropic, Legislation, Occupational responsibility, Toxicity, Mental health, Australia, Oceania, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0403175

    Code Inist : 002B18H05C. Création : 25/01/1999.